Click Here for 5% Off Your First Aladdin Purchase!

KML 29 - 96%, high purity , CAS No.1380424-42-9, Inhibitor of Monoacylglycerol lipase

  • Moligand™
  • ≥96%
Item Number
K287859
Grouped product items
SKUSizeAvailabilityPrice Qty
K287859-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$61.90
K287859-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$103.90
K287859-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$234.90
K287859-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$416.90
K287859-100mg
100mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$757.90

Highly potent and selective MAGL inhibitor.

Basic Description

SynonymsKML29|KML-29|1380424-42-9|1,1,1,3,3,3-hexafluoropropan-2-yl 4-[bis(1,3-benzodioxol-5-yl)-hydroxymethyl]piperidine-1-carboxylate|KML 29|1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo[d][1,3]dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate|GTPL9482|CHEM
Specifications & PurityMoligand™, ≥96%
Biochemical and Physiological MechanismsHighly selective and potent monoacylglycerol lipase (MAGL) inhibitor. Exhibits potent inhibition of human, mouse and rat MAGL (IC50values are 5.9, 15 and 43 nM, respectively). Exhibits no detectable inhibition of FAAH (IC50> 50000 nM). Potently and select
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of Monoacylglycerol lipase
Product Description

Product Describtion:

KML29 is an extremely selective, orally active and irreversible inhibitor of MAGL with IC50 of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively.

Associated Targets

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FAAH Tchem Fatty-acid amide hydrolase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MGLL Tchem Monoglyceride lipase 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[bis(1,3-benzodioxol-5-yl)-hydroxymethyl]piperidine-1-carboxylate
INCHI InChI=1S/C24H21F6NO7/c25-23(26,27)20(24(28,29)30)38-21(32)31-7-5-13(6-8-31)22(33,14-1-3-16-18(9-14)36-11-34-16)15-2-4-17-19(10-15)37-12-35-17/h1-4,9-10,13,20,33H,5-8,11-12H2
InChi Key SXHQLPHDBLTFPM-UHFFFAOYSA-N
Canonical SMILES C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)(C4=CC5=C(C=C4)OCO5)O)C(=O)OC(C(F)(F)F)C(F)(F)F
Isomeric SMILES C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)(C4=CC5=C(C=C4)OCO5)O)C(=O)OC(C(F)(F)F)C(F)(F)F
Alternate CAS 1380424-42-9
PubChem CID 71656212
MeSH Entry Terms 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(bis(benzo(d)(1,3)dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate;KML29 compound
Molecular Weight 549.42

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot NumberCertificate TypeDateItem
G2213034Certificate of AnalysisJun 01, 2022 K287859
G2213035Certificate of AnalysisJun 01, 2022 K287859
G2213068Certificate of AnalysisJun 01, 2022 K287859
G2213070Certificate of AnalysisJun 01, 2022 K287859
G2213114Certificate of AnalysisJun 01, 2022 K287859

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 54.94, Max Conc. mM: 100

Related Documents

References

1. Ignatowska-Jankowska BM, Ghosh S, Crowe MS, Kinsey SG, Niphakis MJ, Abdullah RA, Tao Q, O' Neal ST, Walentiny DM, Wiley JL et al..  (2014)  In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects..  Br J Pharmacol,  171  (6): (1392-407).  [PMID:23848221]

Solution Calculators